Log In
Print
BCIQ
Print
Print this Print this
 

Plegridy (Peginterferon beta-1a) (BIIB017)

  Manage Alerts
Collapse Summary General Information
Company Biogen Idec Inc.
DescriptionPegylated interferon (IFN) beta-1a
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentRegistration
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing forms of multiple sclerosis (MS); Treat relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation

U.S. - Fast Track (Treat relapsing-remitting multiple sclerosis (RRMS));
U.S. - Undisclosed Review (Treat relapsing-remitting multiple sclerosis (RRMS));
EU - Standard Review (Treat relapsing-remitting multiple sclerosis (RRMS))

Partner

UCB Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today